Receptor-interacting protein 2 (RIP2) is a kinase that is involved in downstream signaling of nuclear oligomerization domain (NOD)-like receptors NOD1 and 2 sensing bacterial peptidoglycans. RIP2-deficiency or targeting of RIP2 by pharmaceutical inhibitors partially ameliorates inflammatory diseases by reducing pro-inflammatory signaling in response to peptidoglycans. However, RIP2 is widely expressed and interacts with several other proteins suggesting additional functions outside the NOD-signaling pathway. In this review, we discuss the immunological functions of RIP2 and its possible role in autoinflammation and immunity.
Keywords: Apoptosis-associated speck-like protein containing a CARD (ASC); Caspase-1; IL-1β; Inflammasome; Interleukin-1 converting enzyme; NLRP3; NOD1; NOD2; RIPK2.
Copyright © 2020 Elsevier Inc. All rights reserved.